Aclaris Therapeutics, Inc.
Customers
0
None disclosed
Suppliers
1
0 disclosed
Latest period
Dec 31, 2019
10-K filed 2021-03-02
Suppliers 1
Companies that disclose ACRS as a major customer, as a share of their own revenue. 0 active, 1 lapsed.
| Company | % of their revenue | Est. $ from ACRS | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| RIGL RIGEL PHARMACEUTICALS INC |
9% | $5.3M | FY 2019-12-31 | −10.0pp | Lapsed Last seen 2019-12-31 |
10-K 2021-03-02 |
For the year ended December 31, 2019, our three specialty distributors as well as Aclaris, Grifols, Celgene and Kissei (see Note 2) accounted for 74%, 9%, 8%, 6% and 3% of our total revenues, respectively. Aclaris — 19 % — * | ||||||
Alerts are coming
Get an email when ACRS's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.